The U.S. Food and Drug Administration has appealed a lower court ruling that said the regulator missed the mark when it approved genetically engineered salmon for U.S. consumption, a filing in the 9th U.S. Circuit Court of Appeals showed on Tuesday.
The food regulator is appealing a federal judge’s November ruling that concluded the FDA should have considered the consequences of the fish escaping into the wild and mating with native populations, per the National Environmental Policy Act (NEPA). That ruling was seen as a victory for fisheries and food-safety groups who challenged the FDA’s 2015 approval of the fish created and farmed by AquaBounty Technologies Inc.
To read the full story on Westlaw Today, click here: bit.ly/32ed9Mk
Our Standards: The Thomson Reuters Trust Principles.